Provided by Tiger Trade Technology Pte. Ltd.

Benitec Biopharma

10.90
-0.2900-2.59%
Volume:89.51K
Turnover:983.29K
Market Cap:373.38M
PE:-10.33
High:11.25
Open:11.06
Low:10.82
Close:11.19
52wk High:17.15
52wk Low:9.85
Shares:34.25M
Float Shares:20.85M
Volume Ratio:0.71
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0553
EPS(LYR):-1.0472
ROE:-33.50%
ROA:-22.40%
PB:1.99
PE(LYR):-10.41

Loading ...

Biotech firm Benitec's fiscal Q1 net loss widens

Reuters
·
Nov 15, 2025

Benitec Biopharma reports Q1 EPS (22c), consensus (33c)

TIPRANKS
·
Nov 15, 2025

Benitec Biopharma Q1 EPS $(0.22) Beats $(0.41) Estimate

Benzinga
·
Nov 15, 2025

BRIEF-Benitec Biopharma Q1 EPS USD -0.22

Reuters
·
Nov 15, 2025

Benitec Biopharma Q1 Net Income USD -9 Million

THOMSON REUTERS
·
Nov 15, 2025

Press Release: Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update

Dow Jones
·
Nov 15, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 14, 2025

Suvretta Capital Management Reports Acquisition of Benitec Biopharma Common Shares

Reuters
·
Nov 11, 2025

Benitec Biopharma Inc. Files Initial Statement of Beneficial Ownership for Director Sharon Mates

Reuters
·
Nov 08, 2025

Benitec Biopharma Down Over 22%, on Pace for Largest Percent Decrease Since June 2023 -- Data Talk

Dow Jones
·
Nov 07, 2025

BUZZ-Benitec Biopharma tumbles on $100 mln stock offering

Reuters
·
Nov 06, 2025

Benitec Biopharma Inc. Announces Pricing of $100 Million Common Stock Offering

THOMSON REUTERS
·
Nov 06, 2025

BRIEF-Benitec Biopharma Inc. Announces Proposed Public Offering

Reuters
·
Nov 06, 2025

Benitec Biopharma Is Maintained at Market Outperform by Citizens

Dow Jones
·
Nov 04, 2025

Benitec Biopharma price target raised to $22 from $20 at Citizens JMP

TIPRANKS
·
Nov 04, 2025

Benitec Biopharma Inc - 100% Response Rate in Cohort 1 for Bb-301

THOMSON REUTERS
·
Nov 03, 2025

Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301

GlobeNewswire
·
Nov 03, 2025

Benitec Biopharma Announces Appointment of Sharon Mates Ph.d. to Its Board of Directors

THOMSON REUTERS
·
Nov 03, 2025

Press Release: Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors

Dow Jones
·
Nov 03, 2025

Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy

GlobeNewswire
·
Nov 03, 2025